The full story

I started because nothing else worked.

Twenty years from the first prescription Israel ever had to give a patient like me, to building the practice that does it right.

2004 — the seventh prescription

I was diagnosed with Crohn's disease during my military service in 1999. Conventional treatment did what it does — biologics, steroids, the long pharmacological corridor — and for me, like for many Crohn's patients, it ran out before the disease did.

In 2004 I applied directly to Israel's Ministry of Health for a medical cannabis licence. I received the seventh ever issued in the country, and the first granted by direct application — without a prior court order, which had been the entry path for the six patients before me. I was Patient #7.

I did not set out to build anything. I set out to feel better. The building came after, because once I was inside the system I could see how broken it was for everyone else.

2005-2008 — the advocacy years

In 2005 I co-founded the Israel Medical Cannabis Association (IMCA) — the country's first patient-advocacy organization for medical cannabis. I served as chairman until 2016, when Dana Bar-On succeeded me.

The organization was where the policy work happened, but the ground work was patient education. Over and over again I'd watch a newly-licensed patient go to a dispensary, get handed a product, and come back six weeks later having quit because "it didn't work." The product was fine. The patient education was zero.

In 2008 the Ministry of Health licensed me as Israel's first Medical Cannabis Instructor — the formal credential. That same year I built the country's first structured patient education program. In 2012 I built the first nurses' training program.

"What you bring to the conversation, and how specifically you explain yourself, is what changes the outcome. That is true of cannabis, and it is true of AI."

2012 — the Czech Parliament

By 2012 the work in Israel had a track record other countries wanted to look at. Czech officials were preparing to legalize medicinal cannabis (which they did in 2013), and I was invited to address the Czech Parliament's Health Committee. The visit was covered by Hospodářské noviny under the headline "Prosadil konopí jako lék v Izraeli, teď bude přesvědčovat poslance v Česku" ("He pushed through cannabis as medicine in Israel, now he'll convince MPs in Czechia") and by Czech Radio.

I have since advised officials in Bulgaria on similar questions. I am not a politician. I show up, share what worked and what didn't, and leave the rest to the people whose job it is to legislate.

2015 onward — the technology

In 2015 I co-founded Cannaboost, a terpene-technology company. Out of that work came US Patent US11346051B2 — "Aromatized and flavored paper products" — which describes a cold terpene-printing process I'd been developing for years. The patent was granted in 2022. CANNABOOST scaled to over 100,000 units a month.

The product work was its own thing. The thread connecting all of it was the same thread: cannabis is a complex system, and the patient is part of the system, not a passenger in it.

2018-2024 — the operators

The patient-education programs I'd built were eventually adopted by Tikun Olam, BOL Pharma, Bazelet Group, and IMC — Israel's largest licensed cannabis operators. Across those programs we moved average patient retention from approximately four months to thirty-four. The programs were eventually discontinued for internal operational reasons. The patient outcomes were not in dispute.

Ten thousand patients personally guided. Over a hundred thousand onboarded through the system at large.

Now — WIZDOM

Today I'm building WIZDOM. It is the smallest and most focused thing I've ever done. Fifty active clients at a time. A premium 1:1 practice for the cannabis patients who tried the system and watched it fail them. The patients who were told to come back and report and never were given a way to come back, or anyone to report to.

The cannabis side of WIZDOM is what twenty years has prepared me for. The AI side is new. AI lets me do this work at a level of personalization that wasn't possible when I had only my hands and a notebook. But the same trap applies: the appearance of understanding is not understanding. Patients who use AI as a get-out-of-jail-free card for their own accountability use it worse than they'd use a human consultation. The fix is not less AI — it is more accountability.

That is what WIZDOM is built to honor. I am not a doctor. I am the patient who built what the doctors weren't building. I work with the patients who are ready to do the same — to bring cannabis under their own control instead of letting their dispensary, their algorithm, or their hopes decide for them.

Selected milestones with sources

The receipts.

1999

Crohn's diagnosis

Diagnosed during military service. Conventional treatment ran out within years.

2004

Patient #7 — seventh medical cannabis licence in Israel

First Israeli patient to receive a medical cannabis licence by direct application to the Ministry of Health, without a prior court order.

2005

Co-founded the Israel Medical Cannabis Association

Israel's first medical-cannabis patient-advocacy organization. Chairman until 2016.

Hebrew Wikipedia article →
2008

First MoH-licensed Medical Cannabis Instructor

The Ministry of Health licensed the country's first Medical Cannabis Instructor — the formal credential. Built the first structured patient-education program the same year.

2012

Addressed the Czech Parliament Health Committee

Spoke in the run-up to the Czech Republic's 2013 legalization of medicinal cannabis. Coverage in Hospodářské noviny and Czech Radio.

Hospodářské noviny archive →
2012

Built Israel's first nurses' training program for medical cannabis

The companion to the patient-education program — formal training for the clinicians who would carry the protocols.

2015

Co-founded Cannaboost (CEO)

Terpene-technology company. The work that became US Patent US11346051B2.

2016

CannaTech Tel Aviv (speaker)

One of the first international cannabis-industry conferences in Israel. Coverage in Jewish Journal.

2016-2018

Senior consultant — Knesset Medical Cannabis Lobby

Two years embedded in Israel's parliamentary medical-cannabis policy work.

2022

US Patent US11346051B2 granted

Cold terpene-printing technology. CANNABOOST scaled to 100,000+ units/month.

USPTO patent record →
2026

Building WIZDOM

A 50-client capped practice for cannabis patients whose treatment has stopped working. Patient-accountability-first; AI as scaffolding, not as substitute.

For Patients — Start Here →

Want to work together?

If you're a patient, the door is the Rescue Analysis. If you're press, podcast, or a partner — the contact form routes to me.

For Patients Contact